Compare FF & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FF | MBOT |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 145.7M |
| IPO Year | 2005 | 2000 |
| Metric | FF | MBOT |
|---|---|---|
| Price | $3.49 | $2.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 541.9K | ★ 1.5M |
| Earning Date | 03-16-2026 | 03-25-2026 |
| Dividend Yield | ★ 6.88% | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4,200.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.09 | $1.35 |
| 52 Week High | $4.94 | $4.62 |
| Indicator | FF | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 33.94 | 59.50 |
| Support Level | $3.14 | $2.34 |
| Resistance Level | $4.15 | $2.64 |
| Average True Range (ATR) | 0.24 | 0.15 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 0.44 | 64.05 |
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.